Yayın:
Biological Activity Evaluation of Novel Monoamine Oxidase Inhibitory Compounds Targeting Parkinson Disease

Sadeleştirilmiş öğe sayfası
dc.contributor.authorDawbaa, Sam
dc.contributor.authorEVREN, ASAF EVRİM
dc.contributor.authorGÜNDOĞDU KARABURUN, NALAN
dc.contributor.authorSAĞLIK ÖZKAN, BEGÜM NURPELİN
dc.contributor.authorKARABURUN, AHMET ÇAĞRI
dc.contributor.orcid0000-0001-7001-0739
dc.contributor.orcid0000-0002-8651-826X
dc.contributor.orcid0000-0002-0151-6266
dc.contributor.orcid0000-0002-8808-8697
dc.contributor.orcid0000-0002-2503-3824
dc.date.accessioned2025-11-13T10:53:17Z
dc.date.issued2022-11-01
dc.identifier.doihttps://doi.org/10.4155/fmc-2022-0167
dc.identifier.endpage1679
dc.identifier.issn1756-8919
dc.identifier.issue22
dc.identifier.openalexW4307765675
dc.identifier.startpage1663
dc.identifier.urihttps://hdl.handle.net/11421/5562
dc.identifier.urihttps://doi.org/10.4155/fmc-2022-0167
dc.identifier.volume14
dc.language.isoen
dc.relation.ispartofFuture Medicinal Chemistry
dc.rightsrestrictedAccess
dc.subjectMonoamine oxidase
dc.subjectMonoamine oxidase B
dc.subjectChemistry
dc.subjectIn vitro
dc.subjectMonoamine neurotransmitter
dc.subjectPharmacology
dc.subjectEnzyme
dc.subjectBiochemistry
dc.subjectMedicine
dc.subjectSerotonin
dc.subjectReceptor
dc.subject.sdg3
dc.titleBiological Activity Evaluation of Novel Monoamine Oxidase Inhibitory Compounds Targeting Parkinson Disease
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5027469937
local.authorid.openalexA5008980400
local.authorid.openalexA5034941989
local.authorid.openalexA5074136342
local.authorid.openalexA5062259142

Dosyalar

Koleksiyonlar

Publications